Abstract
Extremely high particle stiffness and very low hardness is a serious concern in various mechanical processes in pharmaceutical manufacturing. Here we report an exceptionally high Young’s modulus (E) of ∼ 18 GPa in a drug, isoniazid (INH). This is one of the highest experimentally determined values among all reported pharmaceutical molecular crystals, which we attribute to the presence of a strong three-dimensional (3D) hydrogen bonding network (HBN). Further, we successfully reduced the 3D HBN in INH to 2D in its cocrystal using a co-former, 3,4-dimethylbenzoic acid (DMBA), where its two hydrophobic groups act like protecting groups at supramolecular level and prevent the extension of HBN. This reduced the E in the 1:1 cocrystal, INH-DMBA, by many folds and markedly improved its powder tabletability. To the best of our knowledge, this is the first reliable molecular level approach to alter the stiffness of pharmaceutical crystals and tabletability improvement in a predictable manner, hence, is important in the context of crystal engineering.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
